Jubilant Pharmova’s arm gets 9 observations for Canada facility after USFDA audit

05 Nov 2025 Evaluate

U.S. Food and Drug Administration (USFDA) has concluded audit at Jubilant Pharmova’s arm -- Jubilant HollisterStier General Partnership (JHSGP)’s contract manufacturing facility located in Montreal, Canada on November 3, 2025. 

The USFDA has issued 9 observations pursuant to the completion of audit. JHSGP will submit an action plan on the observations. JHSGP is jointly owned by subsidiaries of Jubilant Pharma, a wholly owned subsidiary of the company. 

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.

Jubilant Pharmova Share Price

951.40 1.15 (0.12%)
21-Jan-2026 15:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.20
Dr. Reddys Lab 1157.80
Cipla 1367.65
Zydus Lifesciences 875.75
Lupin 2138.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×